How Do Treatments for Bipolar Disorder and SUD Affect One Another?
An expert discusses the connections between the 2 highly comorbid diseases and some ways to effectively treat both diseases simultaneously.
Positive Top-Line Phase 3 Data on Novel ADHD Treatment, CTx-1301
New positive data for novel ADHD treatment.
EMPOWERing the Next Generation
An expert discusses recent research evaluating a selective M4 positive allosteric modulator for the treatment of schizophrenia.
Keeping Up With the Times
Have you registered for the 2023 Annual Psychiatric Times World CME Conference?
Paliperidone Palmitate for Schizophrenia: Research on New Innovative Treatment for Unmet Needs
Christoph Correll, MD, shares more on paliperidone palmitate 6-month for the treatment of schizophrenia.
Study Supports Long-Term Efficacy of Esketamine Nasal Spray in Patients With TRD
Investigators noted sustained improvement in depressive symptoms for up to 6.5 years.
Anhedonia in Major Depressive Disorder: Understanding Patient Burden
The relationship of this key symptom of major depressive disorder and patient burden is not well understood. These two posters covered it.
Study Compares Work Productivity Loss, Cost Savings in Esketamine Nasal Spray vs Quetiapine Extended-Release for TRD
“Among employed adults with TRD, esketamine nasal spray treatment was associated with significantly larger improvements in WPL and related costs compared to quetiapine extended-release treatment.”
Paliperidone Palmitate as a Treatment for Schizophrenia
These 3 posters covered the efficacy and safety of paliperidone palmitate in patients with schizophrenia.
First Year International Resident Shares Thoughts on Psychiatry
A psychiatry resident from Mexico reflects on the field.
International Resident's Reflections After US Psychiatric Conference
Introspections from an international resident following a US conference shed light on issues in geriatric psychiatry and more.
New Research, Treatment Issues Featured at Annual Meeting
Did you miss our APA Annual Meeting coverage?
Decentralized Clinical Trials
COVID-19 inspired researchers to devise new approaches to clinical trials.
Annual Meeting Session Highlights the Importance of Building Trainee Communities
How can trainees build and foster communities?
The Importance of Enhancing EDI in Child & Adolescent Psychiatry Training
Poster at annual meeting highlighted the importance of equity, diversity, and inclusion (EDI) training in child and adolescent psychiatry.
Cultivating Diversity Highlighted in Annual Meeting Session
Session at annual meeting discussed the importance cultivating diversity.
Crying at the 2023 APA Annual Meeting
Mental health professionals should cry. Here's why.
Understanding and Managing Behavioral and Psychological Symptoms of Dementia
Recognition is the first and most important step to treating behavioral and psychological symptoms of dementia.
The Week in Review: May 22-26
From the new Surgeon General’s Advisory on Social Media and Youth Mental Health to our exclusive coverage of the 2023 APA Annual Meeting, here are highlights from the week in Psychiatric Times.
“I Know It When I See It”: Definitions of Treatment-Resistant Depression
Presenters at the 2023 APA Annual Meeting compared definitions of treatment-resistant depression.
Changing the Paradigms of How We Think About Depression
Check out this review of the 2023 APA Annual Meeting presentation on the efficacy and safety of repeat treatment courses using novel medicine, zuranolone.
Categorizing the Jewish History of Resilience
Psychiatric Times’ very own H. Steven Moffic, MD, spoke about resilience and religion at the 2023 APA Annual Meeting.
Exploring Affect-Focused Psychotherapies for LGBTQ+ Patients With PTSD at APA 2023
Experts discuss findings from a new trial exploring affect-focused psychotherapies for LGBTQ+ patients with PTSD at the 2023 APA Annual Meeting.
Issues in the Military: A Conversation with Elspeth Ritchie, MD
Learn more about women’s issues, suicide, and PTSD in the military.
Evolution of Pharmacological Treatments at the 2023 APA Annual Meeting
An inside look at what treatments are being discussed in San Francisco...
Trauma, Loss, Resilience, Recovery: Religious Perspectives
How can religion impact resilience?
Annual Meeting Highlights Integrated Care Elective
Session at the annual meeting discussed the importance of integrated care electives.
Poster Highlights Racial/Ethnic Disparities in LAI Use
Data presents opportunities to enhance care and improve treatment adherence.
Poster Examines Accuracy of DID Information on TikTok, YouTube
Poster presented at the 2023 American Psychiatric Association Annual Meeting highlights the good and bad of social media information.
Defining Treatment-Resistant Depression
Does treatment-resistant depression exist? These 2023 APA Annual Meeting panelists discuss definitions in this exclusive video.
2 Clarke Drive Cranbury, NJ 08512